B

BioInvent International AB
STO:BINV

Watchlist Manager
BioInvent International AB
STO:BINV
Watchlist
Price: 50.4 SEK 0.9%
Market Cap: 3.3B SEK
Have any thoughts about
BioInvent International AB?
Write Note

Intrinsic Value

The intrinsic value of one BINV stock under the Base Case scenario is 157.6 SEK. Compared to the current market price of 50.4 SEK, BioInvent International AB is Undervalued by 68%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BINV Intrinsic Value
157.6 SEK
Undervaluation 68%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation Backtest
BioInvent International AB

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BINV cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BINV?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Biotechnology Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about BioInvent International AB

Provide an overview of the primary business activities
of BioInvent International AB.

What unique competitive advantages
does BioInvent International AB hold over its rivals?

What risks and challenges
does BioInvent International AB face in the near future?

Summarize the latest earnings call
of BioInvent International AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for BioInvent International AB.

Provide P/S
for BioInvent International AB.

Provide P/E
for BioInvent International AB.

Provide P/OCF
for BioInvent International AB.

Provide P/FCFE
for BioInvent International AB.

Provide P/B
for BioInvent International AB.

Provide EV/S
for BioInvent International AB.

Provide EV/GP
for BioInvent International AB.

Provide EV/EBITDA
for BioInvent International AB.

Provide EV/EBIT
for BioInvent International AB.

Provide EV/OCF
for BioInvent International AB.

Provide EV/FCFF
for BioInvent International AB.

Provide EV/IC
for BioInvent International AB.

Show me price targets
for BioInvent International AB made by professional analysts.

What are the Revenue projections
for BioInvent International AB?

How accurate were the past Revenue estimates
for BioInvent International AB?

What are the Net Income projections
for BioInvent International AB?

How accurate were the past Net Income estimates
for BioInvent International AB?

What are the EPS projections
for BioInvent International AB?

How accurate were the past EPS estimates
for BioInvent International AB?

What are the EBIT projections
for BioInvent International AB?

How accurate were the past EBIT estimates
for BioInvent International AB?

Compare the revenue forecasts
for BioInvent International AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of BioInvent International AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of BioInvent International AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of BioInvent International AB compared to its peers.

Compare the P/E ratios
of BioInvent International AB against its peers.

Discuss the investment returns and shareholder value creation
comparing BioInvent International AB with its peers.

Analyze the financial leverage
of BioInvent International AB compared to its main competitors.

Show all profitability ratios
for BioInvent International AB.

Provide ROE
for BioInvent International AB.

Provide ROA
for BioInvent International AB.

Provide ROIC
for BioInvent International AB.

Provide ROCE
for BioInvent International AB.

Provide Gross Margin
for BioInvent International AB.

Provide Operating Margin
for BioInvent International AB.

Provide Net Margin
for BioInvent International AB.

Provide FCF Margin
for BioInvent International AB.

Show all solvency ratios
for BioInvent International AB.

Provide D/E Ratio
for BioInvent International AB.

Provide D/A Ratio
for BioInvent International AB.

Provide Interest Coverage Ratio
for BioInvent International AB.

Provide Altman Z-Score Ratio
for BioInvent International AB.

Provide Quick Ratio
for BioInvent International AB.

Provide Current Ratio
for BioInvent International AB.

Provide Cash Ratio
for BioInvent International AB.

What is the historical Revenue growth
over the last 5 years for BioInvent International AB?

What is the historical Net Income growth
over the last 5 years for BioInvent International AB?

What is the current Free Cash Flow
of BioInvent International AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for BioInvent International AB.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
BioInvent International AB

Current Assets 1B
Cash & Short-Term Investments 950.1m
Receivables 51m
Other Current Assets 9.9m
Non-Current Assets 76.5m
Long-Term Investments 29.1m
PP&E 17m
Other Non-Current Assets 30.4m
Current Liabilities 76.1m
Other Current Liabilities 76.1m
Non-Current Liabilities 8.3m
Long-Term Debt 8.3m
Efficiency

Earnings Waterfall
BioInvent International AB

Revenue
38.6m SEK
Operating Expenses
-494.8m SEK
Operating Income
-456.1m SEK
Other Expenses
46.5m SEK
Net Income
-409.7m SEK

Free Cash Flow Analysis
BioInvent International AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BINV Profitability Score
Profitability Due Diligence

BioInvent International AB's profitability score is 9/100. The higher the profitability score, the more profitable the company is.

9/100
Profitability
Score

BioInvent International AB's profitability score is 9/100. The higher the profitability score, the more profitable the company is.

BINV Solvency Score
Solvency Due Diligence

BioInvent International AB's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

BioInvent International AB's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BINV Price Targets Summary
BioInvent International AB

Wall Street analysts forecast BINV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BINV is 73.95 SEK with a low forecast of 55.55 SEK and a high forecast of 94.5 SEK.

Lowest
Price Target
55.55 SEK
10% Upside
Average
Price Target
73.95 SEK
47% Upside
Highest
Price Target
94.5 SEK
88% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BINV?

Click here to dive deeper.

Dividends

BioInvent International AB
does not pay dividends
Shareholder Yield

Current shareholder yield for BINV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

BioInvent International AB

Country

Sweden

Industry

Biotechnology

Market Cap

3.3B SEK

Dividend Yield

0%

Description

BioInvent International AB engages in the research and development of novel and immuno-modulatory antibodies for the treatment of cancer. The company is headquartered in Lund, Skane and currently employs 84 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.

Contact

SKANE
Lund
Gammahuset, Ideongatan 1
+46462868550.0
www.bioinvent.se

IPO

2001-06-12

Employees

84

Officers

President & CEO
Dr. Martin Welschof Ph.D.
Chief Financial Officer
Mr. Stefan Ericsson M.B.A.
Chief Operating Officer
Ms. Marie Moores M.Sc., R.G.N.
Senior Vice President of Technical Operations
Mr. Kristoffer Rudenholm Hansson
Chief Scientific Officer
Mr. Björn Frendéus
Senior Director of Investor Relations
Ms. Cecilia Hofvander
Show More
Chief Medical Officer
Dr. Andres McAllister
Head of Preclinical Research
Ms. Ingrid Teige
Chief Business Officer
Ms. Sylvie Ryckebusch
Senior Vice President of Regulatory Affairs
Dr. Ingunn Munch Lindvig
Show Less

See Also

Discover More
What is the Intrinsic Value of one BINV stock?

The intrinsic value of one BINV stock under the Base Case scenario is 157.6 SEK.

Is BINV stock undervalued or overvalued?

Compared to the current market price of 50.4 SEK, BioInvent International AB is Undervalued by 68%.

Back to Top